Acorda Therapeutics, Inc ACOR

NRPICKS_

Acorda Therapeutics, Inc. a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company markets Ampyra , an oral medication to improve gait in patients with multiple sclerosis (MS).

LadyAmalthea12

@carsonusa5 You know how to read my charts, right?? 🤣 I'm sorry, I'm tired and don't want to do a full analysis... but ONLY ADD AT THE SUPPORT LEVELS (labeled)

We2invest

There is no such things as 100% wins. Always proceed with caution and conduct your own analysis. *Not Financial advice*

NRPICKS_

Acorda Therapeutics, Inc. a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company markets Ampyra, an oral drug to improve gait in patients with multiple sclerosis; Inbrija for the treatment of OFF periods in Parkinson's disease. Its latest quarterly report represents an earnings surprise of 3.15%....

Time_Oracle

Acor may have news soon...looking for a double

LucioN93

This one should be going as soon as it breaks the downside trend line, this should happen soon as it is trading at low BB level and 200 day MA, almost impossible it goes down.

themaster5

ACORDA THERAPEUTICS

AlenCiken

Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into "At The Market" Offering Agreement $80 million up-front payment will substantially increase cash balance Sale, restructuring and other operating expense reductions will reduce annual operating...

TheTradingTraveller

Be ready, I think acorda is going to make a big move soon.

TheTradingTraveller

Acorda has made a very big upside candle, could this mean something? coming out of a bear market for year, this is pretty good news.

SOAP1973

NASDAQ:ACOR 3850 shares order price : 0.77 SL: 0.64 TP : 2

KozakHlib

Contextual immersion trading strategy idea. Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position...

TheTradingTraveller

Right now is a good moment to stack up some acorda stock's & in the future I will come up with an exit plan. I see 1000-2000% Growth potential in this stock. Invest @ 0.75$ and the risk is minimal.

DigitalData

Alright so this is a weekly falling wedge.... when this blows up we are looking at possible explosion, then double bottom etc. My EW prediction is there. I have 5 alerts on this stock I'd highly suggest setting them. No clue "when" but be sure this ones going up fast.

TheBreadMaker

Really like the setup on $ACOR for a buy near $0.74. Sitting at double bottom support level on the daily chart. Has room to move up to $1.20, could flip it in its current trend for 10%+ as well. I’ll look for an entry tomorrow morning.

DigitalData

All, I think ACOR can break the larger trend this week. If not it will of course sell off but around that .70 level is a double bottom actually triple if it happens again. I think best to keep a close eye on this one. Nothing new on pipelines for this yet.

UnknownUnicorn2776162

Don’t care about the company but the pattern is good. Double bottom looking for $1 as buyers step in. Any questions ask below. NASDAQ:ACOR

DigitalData

Guys this beat EPS estimates by quite a bit and looks to be the end of the pattern here really soon. This should break eventually to a big upside and could even be right now. As you can see both sides are being hit in the pattern, however the drag across the bottom, and now trading at what could be a double bottom soon is a sign of being oversold (which it is) and...